Gene expression risk signatures maintain prognostic power in multiple myeloma despite microarray probe set translation-Reference-Cited by-同舟云学术

Gene expression risk signatures maintain prognostic power in multiple myeloma despite microarray probe set translation

Author:

Hermansen N. E. U.¹²,Borup R.³,Andersen M. K.⁴,Vangsted A. J.²⁵,Clausen N. T.⁶,Kristensen D. L.⁷,Nielsen F. C.²³,Gimsing P.¹²^ORCID

Affiliation:

1. Multiple Myeloma Research Laboratory; Department of Haematology; Rigshospitalet; Copenhagen Denmark

2. Department of Clinical Medicine; University of Copenhagen; Copenhagen Denmark

3. Centre for Genomic Medicine; The Diagnostic Centre; Rigshospitalet; Copenhagen Denmark

4. Cytogenetic Laboratory; Department of Clinical Genetics; Rigshospitalet; Copenhagen Denmark

5. Department of Haematology; Roskilde Hospital; Roskilde Denmark

6. Department of Haematology; Herlev Hospital; Herlev Denmark

7. Department of Oncology and Haematology; Naestved Hospital; Naestved Denmark

Publisher

Wiley

Subject

Biochemistry, medical,Clinical Biochemistry,Hematology,General Medicine

Reference39 articles.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. Established and Novel Prognostic Biomarkers in Multiple Myeloma;American Society of Clinical Oncology Educational Book;2017-05